Tullis Health Investors

Bausch + Lomb Acquires Zirgan® (Ganciclovir Ophthalmic Gel 0.15%) From Sirion Therapeutics for the Treatment of Herpetic Keratitis
First Innovation in Ocular Anti-Viral Therapy in U.S. in Three Decades
Synageva Files for Orphan Drug Designation for SBC-102
Being Developed to be the First Enzyme Replacement Therapy to Treat Lysosomal Acid Lipase Deficiency - A Progressive, Often Fatal Disease
Vidacare Corporation Creates Environmentally Friendly EZ-IO® Needle Set Packaging
Smaller Packaging Reduces Environmental Impact and Is Easier to Store